{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:21:28Z","timestamp":1790256088058,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.yrtph.2009.11.005","type":"journal-article","created":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T08:08:24Z","timestamp":1259136504000},"page":"276-289","source":"Crossref","is-referenced-by-count":65,"title":["Prediction of drug-related cardiac adverse effects in humans-B: Use of QSAR programs for early detection of drug-induced cardiac toxicities"],"prefix":"10.1016","volume":"56","author":[{"given":"Anna A.","family":"Frid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin J.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2009.11.005_bib1","first-page":"353","article-title":"Applications of QSAR methods to ion channels. Computational toxicology: risk assessment for pharmaceuticals and environmental chemicals","author":"Aronov","year":"2007"},{"key":"10.1016\/j.yrtph.2009.11.005_bib2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/cr030049y","article-title":"Structure activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches","volume":"105","author":"Benigni","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.yrtph.2009.11.005_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1517\/17425255.3.1.109","article-title":"Toxicological and clinical computational analysis and the US FDA\/CDER","volume":"3","author":"Benz","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.yrtph.2007.07.001","article-title":"Comparison of MC4PC and MDL-QSAR rodent carcinogenicity predictions and the enhancement of predictive performance by combining QSAR models","volume":"49","author":"Contrera","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1979.10","article-title":"Describing the validity of carcinogen screening tests","volume":"39","author":"Cooper","year":"1979","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yrtph.2009.11.005_bib6","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1021\/jm0302703","article-title":"Finding discriminating structural features by reassembling common building blocks","volume":"46","author":"Cross","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2009.11.005_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curren","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.yrtph.2009.11.005_bib8","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/jm040180d","article-title":"Cytochrome P450 in silico: an integrative modeling approach","volume":"48","author":"de Graaf","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2009.11.005_bib9","first-page":"277","article-title":"Applications of QSAR to enzymes involved in toxicology. Computational toxicology: risk assessment for pharmaceuticals and environmental chemicals","author":"Ekins","year":"2007"},{"key":"10.1016\/j.yrtph.2009.11.005_bib10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug Safety"},{"key":"10.1016\/j.yrtph.2009.11.005_bib11a","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/009286150103500134","article-title":"Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999","volume":"25","author":"Fung","year":"2001","journal-title":"Drug Inform. J."},{"key":"10.1016\/j.yrtph.2009.11.005_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1020869118689","article-title":"Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection","volume":"16","author":"Golbraikh","year":"2002","journal-title":"J. Comput.-Aided Mol. Design"},{"key":"10.1016\/j.yrtph.2009.11.005_bib12","first-page":"307","article-title":"Receiver operating characteristic (ROC) methodology: the state of the art","volume":"29","author":"Hanley","year":"1989","journal-title":"Crit. Rev. Diagn. Imaging"},{"key":"10.1016\/j.yrtph.2009.11.005_bib13","first-page":"29","article-title":"Computational toxicology: heading toward more relevance in drug discovery and development","volume":"9","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Drug Disc. Dev."},{"key":"10.1016\/j.yrtph.2009.11.005_bib14","first-page":"725","article-title":"Future of computational toxicology: broad application into human disease and therapeutics. Computational toxicology: risk assessment for pharmaceuticals and environmental chemicals","author":"Johnson","year":"2007"},{"key":"10.1016\/j.yrtph.2009.11.005_bib15","first-page":"176","article-title":"Multicase: a hierarchical computer automated structure evaluation program","volume":"11","author":"Klopman","year":"1992","journal-title":"QSAR"},{"key":"10.1016\/j.yrtph.2009.11.005_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.addr.2006.10.008","article-title":"Progress in QSAR toxicity screening of pharmaceutical impurities and other FDA regulated products","volume":"59","author":"Kruhlak","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.yrtph.2009.11.005_bib17","first-page":"315","article-title":"Computational modeling of receptor-mediated toxicity. Computational toxicology: risk assessment for pharmaceuticals and environmental chemicals","author":"Lill","year":"2007"},{"key":"10.1016\/j.yrtph.2009.11.005_bib18","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.171.3977.1217","article-title":"Signal detectability and medical decision-making","volume":"171","author":"Lusted","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2009.11.005_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1006\/rtph.1998.1259","article-title":"A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software","volume":"28","author":"Matthews","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/17425255.3.1.125","article-title":"In silico approaches to explore toxicity end points: issues and concerns for estimating human health effects","volume":"3","author":"Matthews","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/1570163043334794","article-title":"Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling","volume":"1","author":"Matthews","year":"2004","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yrtph.2005.11.003","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yrtph.2005.10.004","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yrtph.2006.11.002","article-title":"A comprehensive model for reproductive and developmental toxicity hazard identification: I. Development of a weight of evidence QSAR database","volume":"47","author":"Matthews","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/15376510701857379","article-title":"Combined use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows software to achieve high performance, high confidence, mode of action-based predictions of chemical carcinogenesis in rodents","volume":"18","author":"Matthews","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.yrtph.2009.11.005_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.yrtph.2009.11.006","article-title":"Prediction of drug-related cardiac adverse effects in humans-A: Creation of a database of effects and identification of factors affecting their occurrence","volume":"56","author":"Matthews","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.yrtph.2009.01.007","article-title":"Identification of structure activity relationships for adverse effects of pharmaceuticals in humans: C. Use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities","volume":"54","author":"Matthews","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yrtph.2006.10.001","article-title":"A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals","volume":"47","author":"Matthews","year":"2007","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yrtph.2009.01.009","article-title":"Identification of structure\u2013activity relationships for adverse effects of pharmaceuticals in humans: B. Use of QSAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities","volume":"54","author":"Matthews","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib30","unstructured":"MedDRA. Northrop Grumman Corporation. Accessed May 2006, http:\/\/www.meddramsso.com."},{"key":"10.1016\/j.yrtph.2009.11.005_bib31","unstructured":"MicroMedex Integrated Index. Thomson Micromedex. Accessed May 2006\u2013May 2007, (http:\/\/www.micromedex.com\/)."},{"key":"10.1016\/j.yrtph.2009.11.005_bib32","unstructured":"OECD Guidance, 2007. Guidance document on the validation of (quantitative) structure\u2013activity relationship [Q)SAR models (ENV\/JM\/MONO(2007)2, http:\/\/ecb.jrc.ec.europa.eu\/qsar\/background\/index.php?c=OECD)."},{"key":"10.1016\/j.yrtph.2009.11.005_bib33","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1897\/01-171","article-title":"Quantitative structure\u2013activity relationship methods: Perspectives on drug discovery and toxicology","volume":"22","author":"Perkins","year":"2003","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.yrtph.2009.11.005_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1007601015854","article-title":"Robust classification for imprecise environments","volume":"42","author":"Provost","year":"2001","journal-title":"Mach. Learn. J."},{"key":"10.1016\/j.yrtph.2009.11.005_bib35","first-page":"34","article-title":"Physiological based pharacokinetic and pharmacodynamic modeling. Computational toxicology: risk assessment for pharmaceuticals and environmental chemicals","author":"Reisfeld","year":"2007"},{"key":"10.1016\/j.yrtph.2009.11.005_bib36","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/ci0000631","article-title":"LeadScope: software for exploring large sets of screening data","volume":"40","author":"Roberts","year":"2000","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.yrtph.2009.11.005_bib37","unstructured":"Salillas, J., Prous, J., Aragones, D., 2004. Computer aided screening for HIV antiviral activity in the open NCI database. In: XVIII\u2019th International Symposium on Medicinal Chemistry. Copenhagen, Denmark & Malmo, Sweden. Poster 18."},{"key":"10.1016\/j.yrtph.2009.11.005_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1358\/mf.2005.27.5.908643","article-title":"Research on adverse drug events. I. muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes","volume":"27","author":"Silvestre","year":"2005","journal-title":"Meth. Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2008.12.009","article-title":"Identification of structure activity relationships for adverse effects of pharmaceuticals in humans A: use of FDA post market reports to create a database of hepatobiliary and urinary tract toxicities","volume":"54","author":"Ursem","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.11.005_bib40","doi-asserted-by":"crossref","first-page":"5984","DOI":"10.1021\/jm0497242","article-title":"Building predictive models for protein tyrosine phosphatase 1B inhibitors based on discriminating structural features by reassembling medicinal chemistry building blocks","volume":"47","author":"Yang","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2009.11.005_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/157340906777441672","article-title":"The art of data mining the minefields of toxicity databases to link chemistry to biology","volume":"2","author":"Yang","year":"2006","journal-title":"Curr. Comp. Aided Drug Design"},{"key":"10.1016\/j.yrtph.2009.11.005_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00003495-197816010-00002","article-title":"Drug-induced liver disease","volume":"16","author":"Zimmerman","year":"1978","journal-title":"Drugs"},{"key":"10.1016\/j.yrtph.2009.11.005_bib43","series-title":"Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver","author":"Zimmerman","year":"1999"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323000900227X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323000900227X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T21:45:10Z","timestamp":1558647910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323000900227X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S027323000900227X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2009.11.005","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}